ARDELYX, INC. (ARDX)

↓ Download CSV

CIK 0001437402 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, ARDELYX, INC. reported revenue of $407.32M, up 22.1% from the prior year. The company ran a net loss, with a net margin of -15.1%. It held $501.60M in total assets against $334.65M in total liabilities.

Key ratios (FY2025)

-10.1%
Operating margin
-15.1%
Net margin
-36.9%
Return on equity
+22.1%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$407.32M$333.62M$124.46M$52.16M$10.10M$7.57M$5.28M$2.61M$42.00M
Cost of Revenue$39.54M$50.56M$17.80M$4.12M$1.00M
Gross Profit$4.68M$2.14M$33.60M
Operating Income-$40.98M-$27.95M-$63.28M-$63.76M-$154.35M-$90.78M-$91.26M-$90.95M-$65.11M-$112.89M
Net Income-$61.60M-$39.14M-$66.07M-$67.21M-$158.16M-$94.31M-$94.94M-$91.30M-$64.34M-$112.39M
EPS (Diluted)$-0.26$-0.17$-0.30$-0.42$-1.52$-1.05$-1.47
Total Assets$501.60M$435.75M$297.58M$190.07M$149.91M$201.56M$259.78M$183.33M$157.90M$213.13M
Total Liabilities$334.65M$262.46M$130.76M$91.74M$67.30M$75.45M$73.13M$67.52M$18.59M$19.98M
Shareholders' Equity$166.95M$173.29M$166.82M$98.33M$82.62M$126.11M$186.66M$115.81M$139.31M$193.15M
Cash & Equivalents$68.00M$64.93M$21.47M$96.14M$72.43M$91.03M$181.13M$78.77M$75.38M$74.60M
Operating Cash Flow-$42.48M-$44.81M-$89.72M-$70.04M-$152.55M-$81.44M-$76.48M-$70.27M-$65.19M-$92.53M
Capital Expenditures$1.49M$1.01M$344.0K$55.0K$1.87M$324.0K$325.0K$311.0K$2.35M$4.87M
Shares Outstanding244.35M238.02M232.45M198.58M130.18M93.60M88.82M62.52M47.53M47.31M